Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
25
YI Quote, Financials, Valuation and Earnings
Last price:
$0.82
Seasonality move
:
25.31%
Day range:
$0.73 - $0.83
52-week range:
$0.55 - $1.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
--
Volume:
83.2K
Avg. volume:
153.6K
1-year change:
-46.98%
Market cap:
$66.3M
Revenue:
$2.1B
EPS (TTM):
-$0.44
Analysts' Opinion
-
Consensus Rating111 has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, 111 has an estimated upside of 675.63% from its current price of $0.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.77.
Fair Value
-
According to the consensus of 0 analysts, 111 has 675.63% upside to fair value with a price target of -- per share.
YI vs. S&P 500
-
Over the past 5 trading days, 111 has underperformed the S&P 500 by -5.89% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
111 does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
111 revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter 111 reported revenues of $502.9M.
Earnings Growth
-
111 has grown year-over-year earnings for 0 quarters straight. In the most recent quarter 111 reported earnings per share of -$0.03.
Enterprise value:
141M
EV / Invested capital:
2.08x
Price / LTM sales:
0.03x
EV / EBIT:
--
EV / Revenue:
0.07x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
9.48x
Price / Operating cash flow:
4.46x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$117.2M
Return On Assets:
-8.36%
Net Income Margin (TTM):
-1.74%
Return On Equity:
-89.07%
Return On Invested Capital:
-47.45%
Operating Margin:
0.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2B | $2.1B | $2B | $506.5M | $502.9M | |
| Gross Profit | $120.8M | $126.2M | $117.2M | $26.3M | $29.4M | |
| Operating Income | -$56.3M | -$35.4M | -$27.4M | -$11.1M | $331.2K | |
| EBITDA | -$55.3M | -$33M | -$25.6M | -$10.8M | $608K | |
| Diluted EPS | -$0.76 | -$0.60 | -$0.44 | -$0.15 | -$0.03 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $379.6M | $431.1M | $391.8M | $437.8M | $411.7M | |
| Total Assets | $398.6M | $483.9M | $428.7M | $460.6M | $432.1M | |
| Current Liabilities | $259.2M | $314.7M | $316.9M | $408.6M | $377.9M | |
| Total Liabilities | $267.4M | $339.9M | $333M | $417.4M | $388.2M | |
| Total Equity | $131.2M | $143.9M | $95.7M | $43.2M | $43.9M | |
| Total Debt | $26.2M | $17.1M | $32.2M | $47.9M | $24M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$61.4M | -$25.4M | $14.9M | $6.1M | $15.5M | |
| Cash From Investing | $39.3M | -$4.7M | $8.7M | $323.7K | $6.9M | |
| Cash From Financing | $29.5M | $31.5M | -$50.8M | $14.8M | -$15.6M | |
| Free Cash Flow | -$61.4M | -$25.4M | $14.9M | $6.1M | $15.5M | |
YI
Sector
Market Cap
$66.3M
$339.9M
Price % of 52-Week High
41.84%
73.76%
Dividend Yield
0%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
-46.98%
-13.42%
Beta (5-Year)
0.414
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.79
200-day SMA
Sell
Level
$0.97
Bollinger Bands (100)
Sell
Level
0.65 - 0.95
Chaikin Money Flow
Sell
Level
-12.5M
20-day SMA
Sell
Level
$0.79
Relative Strength Index (RSI14)
Buy
Level
50.47
ADX Line
Buy
Level
16.26
Williams %R
Neutral
Level
-73.8589
50-day SMA
Buy
Level
$0.75
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Sell
Level
-12.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0354)
Sell
CA Score
(Annual)
Level (-2.1385)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.0285)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
Stock Forecast FAQ
In the current month, YI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The YI average analyst price target in the past 3 months is --.
-
Where Will 111 Stock Be In 1 Year?
According to analysts, the consensus estimate is that 111 share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About 111?
Analysts are divided on their view about 111 share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 111 is a Sell and believe this share price will drop from its current level to --.
-
What Is 111's Price Target?
The price target for 111 over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is YI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for 111 is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of YI?
You can purchase shares of 111 via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 111 shares.
-
What Is The 111 Share Price Today?
111 was last trading at $0.82 per share. This represents the most recent stock quote for 111. Yesterday, 111 closed at $0.77 per share.
-
How To Buy 111 Stock Online?
In order to purchase 111 stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
